Evidence map›Paper›PMID 30373537›Full record

ArticleBMC pregnancy and childbirth2018

Implementation of community based advance distribution of misoprostol in Himachal Pradesh (India): lessons and way forward.

Rakesh Parashar, Anadi Gupt, Devina Bajpayee, Anil Gupta, Rohan Thakur, Ankur Sangwan, Anuradha Sharma, Deshraj Sharma, Sachin Gupta, Dinesh Baswal and 2 more

Abstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rakesh ParasharHealth Systems, USAID-VRIDDHI/IPE Global, New Delhi, India.
Anadi GuptMaternal Health, Department of Health and Family Welfare, Government of Himachal Pradesh, Shimla, India.
Devina BajpayeeMaternal and Newborn Health, USAID-VRIDDHI/IPE Global, New Delhi, India.
Anil GuptaUSAID-VRIDDHI/IPE Global, Shimla, Himachal Pradesh, India.
Rohan ThakurUSAID-VRIDDHI/IPE Global, Mandi, Himachal Pradesh, India.
Ankur SangwanUSAID-VRIDDHI/IPE Global, Kinnaur, Himachal Pradesh, India.
Anuradha SharmaDepartment of Health and Family Welfare, Government of Himachal Pradesh, Mandi, Himachal Pradesh, India.
Deshraj SharmaDepartment of Health and Family Welfare, Government of Himachal Pradesh, Mandi, Himachal Pradesh, India.
Sachin GuptaMaternal and Child Health, USAID-India, New Delhi, India.
Dinesh BaswalMaternal Health, Ministry of Health and Family Welfare, Government of India, New Delhi, India.
Gunjan TanejaUSAID-VRIDDHI/IPE Global, New Delhi, India.
Rajeev GeraUSAID-VRIDDHI/IPE Global, New Delhi, India. rgera@ipeglobal.com.ORCID http://orcid.org/0000-0002-6841-618X

Funding

United States Agency for International Development AID-386-A-14-00001
6 · The paper itself

Abstract

backgroundPostpartum Hemorrhage remains the leading cause of maternal mortality. To prevent PPH, Misoprostol tablet in a dose of 600 micrograms is recommended for use immediately after childbirth in home deliveries wherein the use of oxytocin is difficult. The current article describes an implementation of "community based advance distribution of Misoprostol program" in India which aimed to design an operational framework for implementing this program.

methodsThe intervention was carried out in Janjheli block in Mandi district of the state of Himachal Pradesh which is a mountainous terrain with limited geographical access and reported 90% home deliveries in the year 2014-15. An operational framework to implement program activities was designed which was based on WHO HSS building blocks. Key implementing steps included- Ensuring local ownership through program leadership, forecasting and procurement of 600 mcg misoprostol tablets, training, branding and communication, community engagement and counselling, recording and reporting, monitoring, supportive supervision and feedback mechanisms.

resultsOver the one year of implementation, 512 home deliveries were reported, out of which 89% received the tablets and 84% consumed the tablet within one minute of delivery. No incidence of PPH in tablet consuming mothers was reported. On account of periodic counselling and effective community engagement the intervention also contributed to better tracking of pregnancies till delivery and institutional delivery rates which increased to 93% from 45% and 57% from 11% respectively as compared to the preceding year.

conclusionsThe model has successfully shown the use of single misoprostol tablets of 600 mcg, first time in this program. We also demonstrated a HSS based operational framework, based on which the program is being scaled to additional blocks in Himachal Pradesh as well as to other states of India.

Indexed as

Delivery of Health CareFemaleHumansIndiaMaternal Health ServicesMisoprostolOxytocicsParturitionPostpartum HemorrhagePregnancyProgram EvaluationMisoprostolOxytocicsMaternal mortalityMisoprostolPost-partum hemorrhage

Identifiers

PMID30373537
PMCPMC6206722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.